Recent Updates
Recently added Catalysts
OABI Positive Sentiment

OmniAb to Participate in Upcoming Investor Conferences

Wednesday, August 26, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: OmniAb, Inc. has announced its participation in two upcoming investor conferences, the Nasdaq/LD Micro Summit and the H.C. Wainwright 28th Annual Global Investment Conference. These events are scheduled for September 9 and September 15, 2026, respectively. The company's involvement in these conferences underscores its commitment to engaging with the investment community and promoting its advanced therapeutic discovery technologies.

Market Sentiment Analysis

POSITIVE FACTORS

  • OmniAb is actively engaging with investors.
  • Participation in notable conferences highlights company visibility.
  • Focus on next-generation therapeutics showcases innovation.

Full Press Release Details

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $OABI #OABI--OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced management’s participation in the following upcoming investor conferences: Nasdaq/LD Micro Summit Series Date: Wednesday, September 9, 2026 H.C. Wainwright 28th Annual Global Investment Conference Date: Tuesday, September 15, 2026 The Nasdaq/LD Micro Summit will take place at the Nasdaq Headquarters in

Frequently Asked Questions

What conferences will OmniAb participate in?

OmniAb will participate in the Nasdaq/LD Micro Summit and H.C. Wainwright 28th Annual Global Investment Conference.

When is the Nasdaq/LD Micro Summit scheduled?

The Nasdaq/LD Micro Summit is scheduled for September 9, 2026.

What is the focus of OmniAb's technology?

OmniAb focuses on discovery research technology for next-generation therapeutics.

When will the H.C. Wainwright conference take place?

The H.C. Wainwright 28th Annual Global Investment Conference will take place on September 15, 2026.

ShareAdd on Google
Tags: OABI Viatris Investor Conferences Healthcare OmniAb investor conference therapeutics Nasdaq
Last updated: Aug 26, 2026

Biotech snapshot

Cash runway
$52M liquidity · $0M/mo burn
Low dilution risk